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ABSTRACT
Oxidative damage is thought to be a major cause of the progression of dopamine 
(DA)rgic neurodegeneration as in Parkinson’s disease. We have previously reported 
that tetrahydrobiopterin (BH4), an endogenous molecule required for DA synthesis, 
exerts oxidative stress to DA-producing cells and facilitates the production of DA 
quinone. It is known that aconitase, present in both mitochondrial and cytosolic forms, 
act as an reactive oxygen species (ROS) sensor, and that their inactivation leads to 
further generation of ROS. In the present study we investigated whether the BH4- 
associated vulnerability of DA cells might involve aconitase. In DArgic cell line CATH.a, 
BH4 treatment caused reduction of activity of both mitochondrial and cytosolic aco-
nitases, and this appeared to be due to direct inactivation of the pre-existing enzyme 
molecules. Although most of the activity reduced by BH4 was increased upon re-
activation reaction under a reducing condition, the restoration was not complete, 
suggesting that irreversible and covalent modification has occurred. The aconitase 
inactivation was exacerbated in the presence of DA and attenuated in the presence of 
tyrosine hydroxylase inhibitor a-methyl-p-tyrosine, suggesting the involvement of DA. 
The degree of inactivation increased when the cells were treated with the quinone 
reductase inhibitor dicoumarol and decreased in the presence of quinone reductase 
inducer sulforaphane. Taken together, BH4 appeared to lead to both reversible and 
irreversible inactivation of aconitase and that this is facilitated by the presence of DA 
and accumulation of DA quinone.
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INTRODUCTION
    The  exact  cause  of  selective  degeneration  of 
dopamine  (DA)  cells  in  Parkinson’s  disease  (PD) 
remains  unknown,  but  free  radical-mediated  oxi-
dative  stress  is  thought  to  play  a  major  role. 
Overwhelming  evidence,  particularly  in  post-mortem 
studies  of  human  PD  brain,  indicates  that  oxidative 
damage  evoked  by  reactive  oxygen  species  (ROS) 
participates  in  the  progression  of  DArgic  neurode-
generation.
    We have previously demonstrated that tetrahydro-
bioperin  (BH4),  an  endogenous  molecule  required 
for  DA  synthesis,  exerts  oxidative  stress  to  DA- 
producing cells (Choi et al., 2000; 2003; Lee et al., 24 Nam  Soo  Yoon,  et  al.
2007).  BH4  undergoes  oxidation  during  the  hyd-
roxylation  reaction  (Davis  and  Kaufman,  1993)  as 
well  as  nonenzymatic  auto-oxidation  (Fisher  and 
Kaufman,  l973;  Davis  et  al.,  l988)  to  produce 
hydrogen  peroxide  and  superoxide  radical.  BH4 
thus  facilitates  the  oxidation  of  DA,  producing  DA 
quinone.  Unless  the  quinone  is  removed  by  the 
enzyme  quinone  reductase,  oxygen  radicals  are 
further formed during its redox cycling. As such, DA 
quinone  is  thought  to  cause  mitochondrial  dysfunc-
tion including disruption of membrane potential (Lee 
et  al.,  2002)  and  increased  mitochondrial  swelling 
(Berman and Hastings, 1999). In addition, DA quin-
one  is  thought  to  mediate  α-synuclein-associated 
neurotoxicity  in  PD  by  covalently  modifying  α- 
synuclein  monomer  (Dunnett  and  Bjorklund,  1999) 
and by stabilizing the toxic protofibrillar α-synuclein 
(Conway  et  al.,  2001).
    The  enzyme  aconitase,  an  enzyme  in  the  Krebs 
cycle, is known to be a sensitive index of oxidative 
stress.  As  a  sulfur/iron  protein,  the  enzyme  is 
reversibly  inactivated,  resulting  in  slowing  down  of 
the  Kreb’s  cycle.  In  addition,  studies  have  demon-
strated  that  the  inactivation  of  mitochondrial  aconit-
ase  results  in  generation  of  hydrogen  peroxide and 
free  iron  (Flint  et  al.,1993;  Vasquez-Vivar  et  al., 
2000;  Cantu  et  al.,  2009).  The  free  iron  can 
mediate  Fenton  reaction,  which  in  turn  catalyzes 
further  generation  of  intracellular  ROS.
    Based  on  this  background  information,  it  was 
possible  to  hypothesize  that  BH4  may  lead  to 
inactivation  of  mitochondrial  aconitase  and  that  this 
further  contributes  to  the  generation  of  ROS  and 
cell  death.  We  show  in  the  present  study  that 
exposure  to  BH4  leads  to  both  reversible  and 
irreversible inactivation of  aconitase and that this is 
facilitated  by the  presence of  DA  and accumulation 
of  DA  quinone. 
MATERIALS  AND  METHODS
Materials
    All  culture  media,  fetal  bovine  serum  (FBS), 
horse serum, L-glutamine, trypsin/EDTA, and pen-
icillin-streptomycin  were  from  GibcoBRL  (Gaither-
sburg,  MD,  USA).  BH4,  sulforaphane,  dicoumarol, 
isocitrate, α-methyl-p-tyrosine and ferrous ammonium 
sulfate  were  purchased  from  Sigma  Chemical  (St. 
Louis, MO, USA). All other chemicals were reagent 
grade and were from Sigma or Merck (Rahway, NJ, 
USA).
Cell  culture
   CATH.a cells were grown in RPMI 1640 suppl-
emented with 8% horse serum and 4% FBS. Cells 
were  grown  as  monolayers  in  the  presence  of  100 
IU/l  penicillin  and  10μg/ml  streptomycin  at  37
oC  in 
5% CO2 in humidified atmosphere. For experiments, 
the  cells  were  plated  on  polystyrene  tissue  culture 
dishes  at  a  density  of  1.5∼2×10
5  cells/well  in  24 
well culture plates or 3×10
6 cells/60 mm plate. After 
24  h,  the  cells  were  fed  with  fresh  medium  and 
treated  with  BH4  and/or  other  drugs.
Aconitase  enzyme  assay
    Cells were lysed in ice-cold lysis buffer containing 
0.6 mM MnCl2, 1 mM L-cysteine, 1 mM citrate, and 
0.5% Triton-X 100 in 50 mM Tris-HCl (pH 7.4). The 
aconitase activity was measured spectrophotometr-
ically  by  monitoring  the  formation  of  cis-aconitate 
from  isocitrate  at  240  nm  in  50  mM  Tris-HCl  (pH 
7.4) containing 0.6 mM MnCl2 and 20 mM isocitrate 
at 25
oC (Gardner and Fridovich, 1992). Reactivation 
of  aconitase  was  performed  by  incubating  the  cell 
lysate  for  30  min  in  the  presence  of  50  mM 
dithiothreitol,  200μM  Na2S,  and  200μM  ferrous 
ammonium  sulfate  in  50  mM  Tris-HCl  (pH  8.0)  at 
37
oC.
Mitochondrial  fractionation
    Mitochondrial  fraction  was  prepared  as  described 
by  Menzies  et  al.  (2002).  Cells  grown  on  100  mm 
culture  dish  were  harvested  and  washed  in  pho-
sphate  buffered  saline  (PBS),  homogenized  on  ice 
in  10  volume  of  250  mM  sucrose  with  0.1  mM 
EGTA  and  2  mM  HEPES,  pH  7.4,  using  a  glass- 
Teflon  homogenizer,  and  the  homogenates  were 
centrifuged at 900×g for 6 min at 4
oC. Mitochondrial 
pellet  and  cytosolic  fraction  were  obtained  by 
centrifugation of the supernatant at 16,000×g for 10 
min.
Data  analyses
    Comparisons were made using ANOVA and New-
man-Keuls  multiple  comparisons  test.  p＜0.05  was 
considered  statistically  significant  for  all  analyses.Aconitase  Inactivation  by  BH4 25
Fig.  1.  Aconitase  is  inactivated  by  BH4.  Aconitase  enzyme 
activity was determined in the lysate of CATH.a cells exposed to 
(A) 100μM BH4 for various durations; (B) various concentrations 
of BH4 for 3 h; and in the cell lysate that had been coincubated 
with  (C)  100μM  BH4  for  various  durations  and  (D)  various 
concentrations  of  BH4  for  30  min.  (E)  Aconitase  enzyme  activity 
was  also  determined  in  the  cytosolic  and  mitochondrial  fractions 
of  CATH.a  cells  that  had  been  treated  with  100μM  BH4  for  3 
and 24 h. Data are expressed as the mean±SEM in percentage 
o f  c o n t r o l ;  * p ＜0.05,  **p＜0.01  vs.  untreated  control.
RESULTS
BH4  leads  to  inactivation  of  aconitase
    We  first  tested  whether  exposure  of  DArgic  cells 
to  BH4  might  cause  reduction  of  aconitase  activity. 
CATH.a  cells,  the  cell  line  extensively  used  to 
investigate  DArgic  cell  death  as  an  in  vitro  PD 
model,  was  treated  with  100μM  BH4,  as  this  con-
centration  was  previously  determined  to  exert  pref-
erential  toxicity  to  DArgic  cells  (Choi  et  al.,  2000; 
2003).  As  shown  in  Fig.  1A,  the  exposure  to  BH4 
indeed  resulted  in  a  decrease  in  cellular  aconitase 
activity:  A  reduction  to  81%  was  obtained  within  3 
h,  which  was  further  decreased  to  24  h.  The  red-
uction  was  already  evident  at  a  concentration  as 
low as 10μM (Fig. 1B). Since the exposure of cells 
to  BH4  might  have  also  caused  a  change  in  the 
amount  of  aconitase  protein  as  well  as  inactivation 
of the pre-existing aconitase, we sought to examine 
the  direct  effect  of  BH4  on  aconitase  by  subjecting 
lysate  of  untreated  CATH.a  cells  to  BH4.  The  res-
ults showed that this exerted a more immediate and 26 Nam  Soo  Yoon,  et  al.
Fig. 2. Aconitase inactivation by BH4 is partially irreversible. The 
lysate  of  CATH.a  cells  that  had  been  exposed  to  100μM  BH4 
for  24  h  was  obtained  and  incubated  in  reactivation  solution. 
Aconitase  enzyme  activity  was  measured  and  expressed  as  the 
mean±SEM  in  percentage  of  control.
Fig.  3.  DA  is  involved  in  the  aconitase  inactivation.  Cells  were 
treated  with  100μM  BH4  for  24  h  in  the  presence  of  dopamine 
(100μM)  or  after  a  24  h-pretreatment  with  100μM  α-methyl- 
p-tyrosine.  Aconitase  enzyme  activity  was  measured  in  the  cell 
l y s a t e  a n d  e x p r e s s e d  a s  t h e  m e a n ±SEM  in  percentage  of  con-
trol;  *p＜0.05,  **p＜0.01  vs.  untreated  control: 
＋p＜0.05, 
＋＋p＜
0.01vs.  BH4-treated.
dramatic  effect.  At  100μM  BH4,  the  aconitase 
activity  was  reduced  immediately  within  15  min  to 
7.7%  of  untreated  control  (Fig.  1C).  A  significant 
decrease  was  also  observed  at  10μM  BH4  (Fig. 
1D).  Therefore,  it  appeared  that  the  activity  of  the 
existing  enzyme,  rather  than  a  change  in  gene 
expression,  is  involved  in  the  BH4-  induced  red-
uction  of  aconitase  activity.  Because  aconitase  is 
present  in  the  cytosol  as  well  as  in  the  mit-
ochondria,  we  asked  whether  one  form  might  be 
affected  more  than  the  other.  For  this,  we  frac-
tionated  the  lysate  of  cells  that  had  been  exposed 
to  BH4  into  mitochondrial  and  cytosolic  fractions 
and  subjected  each  to  aconitase  activity  assay.  As 
shown  in  Fig.  1E,  the  activity  of  both  forms  was 
equally  decreased  by  BH4.
The  inactivation  is  partially  irreversible
    It  has  been  reported  that  aconitase  acts  as  a 
ROS  sensor  and  that  its  inactivation  by  ROS  is 
reversible. Therefore, we tested whether the activity 
reduced by the BH4 exposure might be restored by 
reactivation. For this, the lysate of cells treated with 
BH4  for  24  h  was  exposed  to  dithiothreitol,  Na2S 
and ferrous ammonium sulfate. The results showed 
that  the  enzyme  activity  was  recovered  to  87%  of 
untreated  control,  from  66%  before  the  reactivation 
(Fig.  2).  About  34%  of  the  activity  reduced  by  the 
BH4  treatment  could  not  be  recovered,  indicating 
that  the  BH4-induced  inactivation  was  only  partially 
reversible.  This  suggested  that  irreversible  covalent 
modification  might  also  have  occurred.
DA  is  involved  in  the  aconitase  inactivation
    We  have  previously  observed  that  DA  makes 
cells  vulnerable,  and  that  this  is  because  in  the 
presence  of  BH4,  DA  is  readily  oxidized  to  DA 
quinone.  We  therefore  tested  whether  the  addition 
of  DA  may  exacerbate  the  effect  of  BH4  on  aco-
nitase. Cells were coincubated with 100μM DA and 
100μM  BH4,  and  the  degree  of  inactivation  was 
compared with that of cells treated with BH4 alone. 
As  shown  in  Fig.  3,  DA  further  lowered  the  aco-
nitase  activity  from  66%  to  45%,  suggesting  that 
DA  amplified  the  inactivation.  For  further  confirm-
ation,  we  depleted  the  DA  content  in  the  cell  with 
100μM  α-methyl-  p-tyrosine,  the  inhibitor  of  tyros-
ine  hydroxylase,  before  exposing  the  cells  to  BH4. 
In  this  case,  the  aconitase  inactivation  was  not  as 
dramatic  (88%  of  untreated  control).  Taken 
together,  the  presence  of  DA  in  DArgic  cells 
appeared  to  contribute  to  inactivation  of  aconitase.Aconitase  Inactivation  by  BH4 27
Fig.  4.  DA  quinone  is  involved  in  the  aconitase  inactivation. 
Cells  were  treated  with  100μM  BH4  for  24  h  after  a  24  h- 
pretreatment  with  2.5μM  sulforaphane  or  in  the  presence  of 
dicoumarol (10μM). Aconitase enzyme activity was measured in 
the  cell  lysate  and  expressed  as  the  mean±SEM  in  percentage 
of  control;  *p＜0.05,  **p＜0.01  vs.  untreated  control: 
＋p＜0.05, 
＋＋p＜0.01  vs.  BH4-treated.
DA  quinone  is  involved  in  the  aconitase  in-
activation
    Because  the  oxidation  of  DA  to  DA  quinone  is 
thought  to  potentiate  generation  of  ROS  in  DArgic 
cells,  we  tested  whether  removal  of  DA  quinone 
might  attenuate  the  inactivation.  For  this,  the  cells 
were  pretreated  with  sulforaphane,  the  compound 
known  to  elevate  gene  expression  of  quinone  red-
uctase,  at  conditions  previously  shown  to  induce 
quinone  reductase  in  CATH.a  cells  (Han  et  al., 
2007).  Under  this  condition,  the  degree  of  inactiv-
ation was smaller (85% of untreated control; Fig. 4). 
We also tested whether inhibition of quinone reduct-
ase  might  have  a  worsening  effect.  Cotreatment  of 
cells with the quinone reductase inhibitor dicoumarol 
(10μM)  resulted  in  further  inactivation  compared 
to  treatment  with  BH4  alone  (45%  of  untreated 
control).
DISCUSSION
    A  role  of  aconitase  inactivation  in  neurodegener-
ative  diseases  has  been  suggested.  Decreased 
aconitase activity is observed in various animal and 
cell  models  of  neurodegeration  including  the  MPTP 
model  of  PD  (Liang  and  Patel,  2004),  the  DJ-1 
mutant  mouse  model  of  PD  (Andres-Mateos  et  al., 
2007), the β-amyloid model of Alzheimer’s disease 
(Longo  et  al.,  2000),  and  superoxide  dismutase-2 
mutant mouse model of amyotropic lateral sclerosis 
(Melov et al., 1999; Liang and Patel, 2004), as well 
as  in  aging  (Yan  et  al.,  1997).  We  demonstrate  in 
the  present  study  that  BH4,  the  endogenous 
molecule  that  leads  to  DArgic  cell  demise  (Choi  et 
al.,  2000;  2003),  also  causes  a  decrease  in 
aconitase  activity.
    The  mitochondrial  aconitase  catalyzes  the  re-
versible isomerization of citrate and isocitrate via its 
intermediate form, cis-aconitate, in the Kreb’s cycle. 
The  cytosolic  aconitase  is  also  known  as  iron 
regulatory  protein  1,  and  acts  as  a  transcription 
factor  binding  to  iron-responsive  elements,  thereby 
inducing  transcripts  of  genes  involved  in  iron  me-
tabolism and/or energy metabolism (Rouault, 2006). 
We  observed  in  the  current  study  that  both  aconit-
ases are inactivated after cellular exposure to BH4. 
As  BH4  is  known  to  facilitate  production  of  super-
oxide  radical  (Fisher  and  Kaufman,  1973;  Davis  et 
al.,  1988;  Davis  and  Kaufman,  1993)  and  the  iron- 
sulfur  center  of  aconitases  is  susceptible  to  in-
activation  by  superoxide  radical  (Gardner  and  Frid-
ovich,  1992;  Hausladen  and  Fridovich,  1994;  Li  et 
al.,  2001),  it  is  likely  that  the  inactivation  of  acon-
itases  by  BH4  involves  superoxide  radical.
    We  also  observed  that  the  inactivation  is  only 
partially  reversible.  The  aconitases  are  thought  to 
act  as  an  ROS  sensor,  inactivated  in  the  presence 
of  ROS  but  reactivated  under  normal  condition. 
Therefore, the activity not recovered by the reactiv-
ation  reaction  would  be  due  to  irreversible  inactiv-
ation.  Indeed  we  have  noted  a  shift  in  mobility  of 
aconitase  upon  2D  gel  electrophoresis,  suggesting 
a covalent modification (data not shown). In DArgic 
neurons,  DA  can  be  auto-oxidized  to  form  reactive 
quinone  species  capable  of  covalently  modifying 
and damaging cellular macromolecules (Hastings et 
al., 1996). An elevated level of auto-oxidation prod-
ucts  of  cytoplasmic  DA  in  the  Parkinsonian  sub-
stantia  nigra  has  been  noted  (Fornstedt  et  al., 
1989;  Spencer  et  al.,  1998).  That  aconitase  is 
irreversibly  inactivated  by  DA  quinone  is  supported 
by  the  finding  that  induction  of  quinone  reductase 
prevented  aconitase  inactivation  and  inhibition  of 
quinone  reductase  amplified  the  inactivation.
    The  irreversibly  inactivated  aconitase  may  trigger 
a vicious cycle of producing hydrogen peroxide and 28 Nam  Soo  Yoon,  et  al.
free  iron,  which  would  in  turn  contribute  to  further 
generation  of  DA  quinone  in  DArgic  cells.  In  addit-
ion,  the  inactivation  of  aconitase  would  interfere 
with  the  Kreb’s  cycle  and  thus  the  normal  product-
ion  of  ATP  and  NADH.  Therefore,  irreversible 
inactivation  of  aconitase  would  ultimately  lead  to 
ATP  depletion  and  cell  death.
    In summary, we show in the present study that in 
DArgic cells, oxidative stress leads to inactivation of 
the  mitochondrial  and  cytosolic  aconitases  and  that 
this  involves  formation  of  both  ROS  and  DA 
quinone.  The  role  of  DA  quinone  in  covalent  and 
irreversible  modification  of  aconitase  in  DArgic 
neurons  may  be  a  factor  that  renders  these  cells 
particularly  vulnerable.
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